USMLE Step 1 — Biochemistry, Genetics, Metabolic Pathways & Storage Diseases
High-yield enzymes, rate-limiting steps, glycogen/lysosomal storage disorders, inborn errors of metabolism, and inheritance patterns.
- Level
- basic
- Languages
- en → en
- Cards
- 32
- Markdown
- USMLE Step 1 — Biochemistry, Genetics, Metabolic Pathways & Storage Diseases (.md)
Flashcards (32)
| # | Front (Term / Question) | Back (Definition / Answer) | Example | Multiple-Choice Options |
|---|---|---|---|---|
| 1 | What genetic mutation causes Huntington disease, what is its inheritance pattern, and what phenomenon explains earlier onset in successive generations? | CAG trinucleotide repeat expansion in the HTT gene on chromosome 4; autosomal dominant. Anticipation occurs primarily during paternal transmission due to repeat expansion in spermatogenesis. | ||
| 2 | What is the biochemical defect in Von Gierke disease (GSD Type I), and what laboratory abnormalities are seen? | Glucose-6-phosphatase deficiency. Presents with severe fasting hypoglycemia, profound lactic acidosis, hyperuricemia (gout), hyperlipidemia, and marked hepatomegaly with doll-like facies. | ||
| 3 | What is the rate-limiting enzyme of beta-oxidation and what molecule inhibits it? | Carnitine palmitoyltransferase-1 (CPT-1 / CAT-1). Malonyl-CoA inhibits CPT-1, preventing newly synthesized fatty acids from immediately undergoing mitochondrial oxidation. | ||
| 4 | What enzyme deficiency causes Maple Syrup Urine Disease (MSUD), and what amino acids accumulate? | Deficiency of the branched-chain alpha-keto acid dehydrogenase complex (BCKDC, requiring thiamine/B1). Leads to toxic accumulation of leucine, isoleucine, and valine, producing sweet burnt-sugar urine and severe ketoacidosis. | ||
| 5 | What enzyme deficiency causes Gaucher disease, and what is the characteristic histological finding? | Glucocerebrosidase (beta-glucosidase) deficiency causing glucocerebroside accumulation. Histology shows 'crumpled tissue paper' lipid-laden macrophages. | ||
| 6 | What is the rate-limiting enzyme of fatty acid synthesis and what allosteric activator promotes its activity? | Acetyl-CoA carboxylase (ACC), which converts acetyl-CoA to malonyl-CoA. Allosterically activated by citrate and inhibited by long-chain fatty acyl-CoA and glucagon/epinephrine phosphorylation. | ||
| 7 | What is the biochemical basis of Lesch-Nyhan syndrome, its inheritance, and hallmark symptoms? | Absent HGPRT (hypoxanthine guanine phosphoribosyltransferase) in purine salvage; X-linked recessive. Characterized by hyperuricemia, gout, aggressive self-mutilation (lip/finger biting), and dystonia/chorea. | ||
| 8 | What is the most common cause of congenital adrenal hyperplasia (CAH), and what serum marker is elevated? | 21-hydroxylase deficiency (CYP21A2). Causes virilization/ambiguous genitalia in females, salt-wasting crisis (hypotension, hyponatremia, hyperkalemia) in neonates, and elevated 17-hydroxyprogesterone. | ||
| 9 | What genetic defect is responsible for Prader-Willi versus Angelman syndrome on chromosome 15q11-q13? | Prader-Willi: loss of paternal expression (maternal uniparental disomy or paternal deletion). Angelman: loss of maternal UBE3A expression (paternal uniparental disomy or maternal deletion). | ||
| 10 | What is the rate-limiting enzyme in urea synthesis and what is its mandatory allosteric activator? | Carbamoyl phosphate synthetase I (CPS I) in mitochondria; allosterically activated by N-acetylglutamate (NAG). | ||
| 11 | What is the defective enzyme and pathway in McArdle disease (Glycogen Storage Disease Type V)? | Skeletal muscle glycogen phosphorylase (myophosphorylase). Patients develop painful muscle cramps and myoglobinuria upon strenuous exercise, without a rise in blood lactate. | ||
| 12 | What enzyme is deficient in classic homocystinuria, and how does it clinically differ from Marfan syndrome? | Cystathionine beta-synthase (CBS) deficiency (requires B6). Both have tall, arachnodactyly stature, but homocystinuria features downward/inward lens subluxation, intellectual disability, and life-threatening thromboembolism; Marfan has upward/outward ectopia lentis and normal intellect. | ||
| 13 | What enzyme is defective in phenylketonuria (PKU), and what amino acid becomes conditionally essential? | Phenylalanine hydroxylase (or its cofactor tetrahydrobiopterin, BH4). Tyrosine becomes an essential amino acid in diet. | ||
| 14 | What is the rate-limiting enzyme of glycolysis, and what are its principal allosteric regulators? | Phosphofructokinase-1 (PFK-1). Activated by AMP and fructose-2,6-bisphosphate (F-2,6-BP); inhibited by ATP and citrate. | ||
| 15 | What is the underlying defect and classic triad of Wernicke encephalopathy? | Thiamine (vitamin B1) deficiency leading to impaired pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase. Triad: acute confusion/encephalopathy, ataxia, and ophthalmoplegia/nystagmus. | ||
| 16 | How do you distinguish Niemann-Pick disease from Tay-Sachs disease clinically and enzymatically? | Niemann-Pick has sphingomyelinase deficiency (sphingomyelin accumulation), 'foam cells' on histology, and hepatosplenomegaly alongside the cherry-red macular spot; Tay-Sachs lacks hepatosplenomegaly. | ||
| 17 | What cellular process is defective in I-cell disease (mucolipidosis type II), and what is the destination of lysosomal enzymes? | Deficiency of UDP-N-acetylglucosamine phosphotransferase prevents mannose-6-phosphate tagging in the Golgi. Lysosomal acid hydrolases are secreted abnormally into the extracellular space/plasma rather than transported to lysosomes. | ||
| 18 | What is the primary enzyme deficiency and accumulated substrate in Tay-Sachs disease? | Deficiency of Hexosaminidase A leading to GM2 ganglioside accumulation. Characterized by progressive neurodegeneration, cherry-red macular spot, and absence of hepatosplenomegaly (unlike Niemann-Pick). | ||
| 19 | What is the rate-limiting enzyme in heme biosynthesis and what cofactor is required? | Aminolevulinate synthase (ALAS-1 in liver, ALAS-2 in erythroid cells), requiring pyridoxal phosphate (vitamin B6). ALAS-2 mutation causes X-linked sideroblastic anemia. | ||
| 20 | What enzyme deficiency causes Fabry disease, and what is its mode of inheritance and classic triad? | Alpha-galactosidase A deficiency (accumulating ceramide trihexoside/Gb3); X-linked recessive. Triad: episodic peripheral neuropathy (acroparesthesias), angiokeratomas, and hypohidrosis; later renal and cardiovascular failure. | ||
| 21 | What enzyme is deficient in Pompe disease (GSD Type II), and what is its distinctive organ involvement? | Lysosomal acid alpha-1,4-glucosidase (acid maltase). Causes severe hypertrophic cardiomyopathy, generalized hypotonia ('floppy baby'), and cardiomegaly leading to early death. | ||
| 22 | What is the enzyme deficiency in alkaptonuria, and what are its pathognomonic clinical features? | Homogentisate 1,2-dioxygenase deficiency in tyrosine degradation. Accumulation of homogentisic acid causes urine turning dark on standing, bluish-black connective tissue pigmentation (ochronosis), and debilitating arthropathy. | ||
| 23 | What is the rate-limiting step and enzyme in de novo purine synthesis? | Glutamine-PRPP amidotransferase, converting PRPP (5-phosphoribosyl-1-pyrophosphate) to 5-phosphoribosylamine. Strongly inhibited by AMP, GMP, and IMP. | ||
| 24 | What is the metabolic defect in hereditary fructose intolerance and why is it more severe than essential fructosuria? | Aldolase B deficiency. Ingested fructose accumulates as intracellular fructose-1-phosphate, trapping cellular inorganic phosphate, halting glycogenolysis and gluconeogenesis, causing profound postprandial hypoglycemia and hepatic failure. | ||
| 25 | What is the enzyme deficiency in Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency, and what are the classic histological findings on peripheral smear? | G6PD deficiency impairs NADPH production in the pentose phosphate pathway, rendering RBCs vulnerable to oxidative stress. Blood smear shows Heinz bodies (denatured hemoglobin precipitates) and bite cells. | ||
| 26 | What is the most common urea cycle disorder, its inheritance, and distinguishing laboratory findings? | Ornithine transcarbamylase (OTC) deficiency; X-linked recessive. Laboratory findings show hyperammonemia, low BUN, elevated urinary orotic acid, and normal/undetectable citrulline. | ||
| 27 | What is the mechanism of uncoupling agents like 2,4-dinitrophenol (DNP) or brown fat thermogenin on oxidative phosphorylation? | They dissipate the mitochondrial proton gradient across the inner mitochondrial membrane, increasing oxygen consumption and electron transport chain activity while releasing energy as heat without ATP synthesis. | ||
| 28 | What is the deficient transporter in Cystinuria, and what type of urinary stones are formed? | Defective renal proximal tubule amino acid transporter for COLA (Cystine, Ornithine, Lysine, Arginine). Cystine precipitates into pathognomonic hexagonal urinary crystals and radiopaque staghorn or calculi. | ||
| 29 | What is the mode of inheritance and chromosomal abnormality in fragile X syndrome? | X-linked dominant with CGG trinucleotide repeat expansion in the FMR1 gene (>200 repeats leading to hypermethylation and gene silencing). Manifests with intellectual disability, macroorchidism, long narrow face, and large ears. | ||
| 30 | What is the biochemical cause and clinical manifestation of Medium-Chain Acyl-CoA Dehydrogenase (MCAD) deficiency? | Deficiency in medium-chain fatty acid oxidation. Presents after fasting or illness with non-ketotic hypoglycemia, lethargy, seizures, hepatic dysfunction, and dicarboxylic aciduria. | ||
| 31 | What enzyme deficiency causes Acute Intermittent Porphyria (AIP), and what characterizes its neurovisceral attacks? | Porphobilinogen deaminase (hydroxymethylbilane synthase). Attacks are triggered by CYP450 inducers/fasting, presenting with the 5 Ps: Painful abdomen, Polyneuropathy, Psychologic disturbance, Port-wine colored urine, and Precipitated by drugs. | ||
| 32 | What enzyme is deficient in classic galactosemia, and how does it clinically present? | Galactose-1-phosphate uridylyltransferase (GALT). Presents in early infancy after milk ingestion with failure to thrive, jaundice, hepatomegaly, infantile cataracts, and increased risk of E. coli sepsis. |